RxDoctor Payments Data

Robert James Iv, MD

Neurological Surgery · Crestview Hills, KYNPI 1952437097

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,804 of the $6,364 with a category attached, or 91.2%. Biogen accounts for 76.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $6,138 and has fallen 99.6% since, to $22 in 2024.

$6,364in general payments, 2019–2025

Across 18 payments — averaging $353.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$5K
  • Microvention, Inc.$1K
  • Imperative Care, Inc$162
  • Terumo Medical Corporation$27
  • Cardiva Medical, Inc.$22
  • Boston Scientific$15
$55,259in research payments, 2019–2025

Across 12 payments — averaging $4604.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$31K
  • Medical Device Business Services, Inc.$20K
  • Sequent Medical, Inc.$4K

What the payments were for

  • Travel & lodging$5,80491%
  • Food & beverage$5609%

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,364 in reported general payments places this provider in the 65th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$88,445
Medicare patients
90
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate15$39

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Crestview Hills

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →